CJC-1295
CJC-1295 (with or without DAC)
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce more growth hormone naturally. Available with DAC (long-acting) or without DAC (modified GRF 1-29).
Pricing Overview
Brand / Retail Price
N/A (research/compounded)
Compounded / Cash Pay
$100–$300/month
Often combined with Ipamorelin at compounding pharmacies for better pricing
Primary Uses
How CJC-1295 Works
CJC-1295 binds to GHRH receptors on the pituitary gland, amplifying the natural pulsatile release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life to 6–8 days by binding to albumin.
Dosing Information
Typical Dose
100–300mcg daily (no DAC) or 2mg weekly (with DAC)
Frequency
Daily (no DAC) or 1–2x weekly (with DAC)
Administration
Subcutaneous injection
Notes
Best taken at bedtime to align with natural GH pulse
Side Effects & Safety
Common
- • Flushing
- • Headache
- • Water retention
- • Tingling/numbness in extremities
Serious
- • Potential blood sugar changes
- • Carpal tunnel symptoms (high dose)
Rare
- • Joint pain
- • Elevated cortisol
Frequently Asked Questions
What is the difference between CJC-1295 with and without DAC?
CJC-1295 with DAC has a longer half-life (6–8 days) and provides sustained GH elevation. Without DAC (mod GRF 1-29) has a shorter half-life (30 min) and produces sharper GH pulses, more closely mimicking natural release. Most clinicians prefer without DAC for better physiologic response.
Related Peptides
Compare CJC-1295 Prices
Upload your CJC-1295 prescription and receive competitive bids from verified compounding pharmacies.
Get CJC-1295 Quotes